NO166447C - Analogifremgangsmaate for fremstilling av terapeutisk virksomt n-(1-cyclohexenylmethyl-2-pyrrolidinylmethyl)-8-ethylsulfonyl-1,5-benzodioxepan-6-carboxamid. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomt n-(1-cyclohexenylmethyl-2-pyrrolidinylmethyl)-8-ethylsulfonyl-1,5-benzodioxepan-6-carboxamid.

Info

Publication number
NO166447C
NO166447C NO863225A NO863225A NO166447C NO 166447 C NO166447 C NO 166447C NO 863225 A NO863225 A NO 863225A NO 863225 A NO863225 A NO 863225A NO 166447 C NO166447 C NO 166447C
Authority
NO
Norway
Prior art keywords
benzodioxepan
cyclohexenylmethyl
ethylsulphonyl
pyrrolidinylmethyl
carboxamide
Prior art date
Application number
NO863225A
Other languages
English (en)
Norwegian (no)
Other versions
NO863225L (no
NO166447B (no
NO863225D0 (no
Inventor
Denis Besancon
Jacqueline Franceschini
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of NO863225D0 publication Critical patent/NO863225D0/no
Publication of NO863225L publication Critical patent/NO863225L/no
Publication of NO166447B publication Critical patent/NO166447B/no
Publication of NO166447C publication Critical patent/NO166447C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
NO863225A 1985-08-12 1986-08-11 Analogifremgangsmaate for fremstilling av terapeutisk virksomt n-(1-cyclohexenylmethyl-2-pyrrolidinylmethyl)-8-ethylsulfonyl-1,5-benzodioxepan-6-carboxamid. NO166447C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8512270A FR2586018B1 (fr) 1985-08-12 1985-08-12 Nouveau benzodioxepanne, son procede de synthese et ses applications en therapeutique

Publications (4)

Publication Number Publication Date
NO863225D0 NO863225D0 (no) 1986-08-11
NO863225L NO863225L (no) 1987-02-13
NO166447B NO166447B (no) 1991-04-15
NO166447C true NO166447C (no) 1991-07-24

Family

ID=9322162

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863225A NO166447C (no) 1985-08-12 1986-08-11 Analogifremgangsmaate for fremstilling av terapeutisk virksomt n-(1-cyclohexenylmethyl-2-pyrrolidinylmethyl)-8-ethylsulfonyl-1,5-benzodioxepan-6-carboxamid.

Country Status (41)

Country Link
US (1) US4762852A (sv)
EP (1) EP0216658B1 (sv)
JP (1) JPS63119482A (sv)
KR (1) KR920006238B1 (sv)
CN (1) CN86106163A (sv)
AR (1) AR242383A1 (sv)
AT (1) ATE49964T1 (sv)
AU (1) AU583645B2 (sv)
BE (1) BE905257A (sv)
BG (1) BG45855A3 (sv)
CA (1) CA1266670A (sv)
CH (1) CH667656A5 (sv)
CS (1) CS255879B2 (sv)
DD (1) DD251978A5 (sv)
DE (2) DE3627197A1 (sv)
DK (1) DK162995C (sv)
EG (1) EG18107A (sv)
ES (1) ES2000960A6 (sv)
FI (1) FI84603C (sv)
FR (1) FR2586018B1 (sv)
GB (1) GB2179040B (sv)
GR (1) GR862100B (sv)
HU (1) HU196392B (sv)
IL (1) IL79436A (sv)
IN (1) IN163319B (sv)
IS (1) IS1444B6 (sv)
IT (1) IT1214711B (sv)
LU (1) LU86542A1 (sv)
MA (1) MA20753A1 (sv)
NO (1) NO166447C (sv)
NZ (1) NZ217101A (sv)
OA (1) OA08382A (sv)
PH (1) PH21419A (sv)
PL (1) PL146385B1 (sv)
PT (1) PT83055B (sv)
SU (1) SU1456012A3 (sv)
TN (1) TNSN86121A1 (sv)
YU (1) YU44589B (sv)
ZA (1) ZA865739B (sv)
ZM (1) ZM6386A1 (sv)
ZW (1) ZW16086A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA735524B (en) * 1972-09-21 1974-07-31 Hoffmann La Roche Therapeutic compositions
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2360305A1 (fr) * 1976-08-04 1978-03-03 Ile De France Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation
FR2396757A2 (fr) * 1977-07-08 1979-02-02 Ile De France Nouveaux 2,3-alkylene bis (oxy) benzamides substitues, leurs derives et leurs procedes de preparation
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
US4379161A (en) * 1979-06-07 1983-04-05 Michel Thominet Novel substituted heterocyclic phenoxyamines, the method of preparation thereof and the use thereof as local anaesthetics

Also Published As

Publication number Publication date
SU1456012A3 (ru) 1989-01-30
DK162995B (da) 1992-01-06
GR862100B (en) 1986-12-30
NO863225L (no) 1987-02-13
IS3123A7 (is) 1987-02-13
AU583645B2 (en) 1989-05-04
DK162995C (da) 1992-06-01
NO166447B (no) 1991-04-15
IL79436A (en) 1990-09-17
DE3627197A1 (de) 1987-03-12
CN86106163A (zh) 1987-04-08
IT8648366A0 (it) 1986-08-07
GB2179040A (en) 1987-02-25
KR870002131A (ko) 1987-03-30
CH667656A5 (fr) 1988-10-31
FI863138A (fi) 1987-02-13
DD251978A5 (de) 1987-12-02
ES2000960A6 (es) 1988-04-01
GB8619550D0 (en) 1986-09-24
IS1444B6 (is) 1990-12-14
OA08382A (fr) 1988-02-29
BG45855A3 (en) 1989-08-15
CS591486A2 (en) 1987-07-16
BE905257A (fr) 1987-02-11
EP0216658A1 (fr) 1987-04-01
AR242383A1 (es) 1993-03-31
FR2586018A1 (fr) 1987-02-13
FI84603B (fi) 1991-09-13
MA20753A1 (fr) 1987-04-01
YU141786A (en) 1987-10-31
ZM6386A1 (en) 1987-02-27
HU196392B (en) 1988-11-28
PL146385B1 (en) 1989-01-31
TNSN86121A1 (fr) 1990-01-01
EP0216658B1 (fr) 1990-01-31
IT1214711B (it) 1990-01-18
PT83055A (fr) 1986-08-01
DK381986A (da) 1987-02-13
FI84603C (sv) 1991-12-27
DK381986D0 (da) 1986-08-11
PH21419A (en) 1987-10-15
NZ217101A (en) 1989-08-29
CS255879B2 (en) 1988-03-15
IL79436A0 (en) 1986-10-31
GB2179040B (en) 1989-08-16
YU44589B (en) 1990-10-31
HUT44783A (en) 1988-04-28
FI863138A0 (fi) 1986-07-31
DE3668619D1 (de) 1990-03-08
CA1266670A (fr) 1990-03-13
IN163319B (sv) 1988-09-03
LU86542A1 (fr) 1986-12-02
JPS63119482A (ja) 1988-05-24
ATE49964T1 (de) 1990-02-15
PL260978A1 (en) 1987-03-09
EG18107A (en) 1991-08-30
NO863225D0 (no) 1986-08-11
US4762852A (en) 1988-08-09
FR2586018B1 (fr) 1988-03-25
KR920006238B1 (ko) 1992-08-01
PT83055B (pt) 1988-07-01
AU6097786A (en) 1987-02-19
ZW16086A1 (en) 1987-05-20
ZA865739B (en) 1987-03-25

Similar Documents

Publication Publication Date Title
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO851949L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO863671D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO163486C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO873835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO158579C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt n-(2-metoksyetyl)-noroksymorfon.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.